INFI Infinity Pharmaceuticals Inc

Infinity Pharmaceuticals Inc is a biopharmaceutical company engaged in discovering, developing and delivering medicines to people with difficult-to-treat diseases.

$3.32
As of 06/18/2021     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  02/20/2001
Outstanding shares:  88,647,241
Average volume:  1,366,556
Market cap:   $296,081,785
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    45665G303
ISIN:        US45665G3039
Sedol:      B1FCQS7
Valuation   (See tab for details)
PE ratio:   -7.14
PB ratio:   5.66
PS ratio:   0.00
Return on equity:   0.00%
Net income %:   0.00%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy